Global pharmaceutical consortium Rx-360 has launched an expansion of its focus on international initiatives, to support its supply chain security. Founded in Philadelphia, USA, in 2009, Rx-360’s goal is to ‘protect patient safety, by sharing information and developing processes related to the integrity of the healthcare supply chain’. Through Rx-360, pharmaceutical companies and suppliers work toRx-360gether to maintain the security of their supply chains.
With globalisation of distribution for both drug components and finished products, the levels of complexity and threats become an ever-increasing challenge”, said Scott Kammer, an Rx-360 Board Member and Secretary and Head of Global Product Protection and Commercial Quality for Takeda Pharmaceutical, Inc. “We cannot work in a vacuum. Participation across the end-to-end supply chain needs focused attention from both the industry and its regulators. Our goal is to expand knowledge, educate others, and partner with all members of the industry as well as regulators across the globe to seek innovative solutions.”
